TAYLOR GLEN A 4

4 · Envoy Medical, Inc. · Filed Mar 13, 2025

Form 4

Period: 2025-03-11

10% Owner

Transactions

Award
Warrant (right to buy)
2025-03-11+750,000→ 750,000 total(indirect: By LLC)
Exercise: $1.35From: 2025-03-11Exp: 2028-03-11→ Class A Common Stock (750,000 underlying)

Holdings

Class A Common Stock
2,953,607
Class A Common Stock
(indirect: By LLC)
4,810,384
Warrant (right to buy)
(indirect: By LLC)
Exercise: $3.04From: 2024-05-23Exp: 2026-02-27→ Class A Common Stock (250,000 underlying)
250,000
Warrant (right to buy)
(indirect: By LLC)
Exercise: $2.20From: 2024-12-11Exp: 2026-08-27→ Class A Common Stock (500,000 underlying)
500,000
Warrant (right to buy)
(indirect: By LLC)
Exercise: $2.97From: 2024-08-27Exp: 2026-08-27→ Class A Common Stock (500,000 underlying)
500,000
Class A Common Stock
(indirect: By Taylor Sports Group)
2,526,058
Warrant (right to buy)
(indirect: By LLC)
Exercise: $1.24From: 2024-02-27Exp: 2026-02-27→ Class A Common Stock (500,000 underlying)
500,000
Warrant (right to buy)
(indirect: By LLC)
Exercise: $2.25From: 2024-07-22Exp: 2026-02-27→ Class A Common Stock (250,000 underlying)
250,000
Series A Preferred Stock
(indirect: By LLC)
Exercise: $11.50→ Class A Common Stock (869,565 underlying)
1,000,000

Footnotes (4)

[F1]The Reporting Person is the owner and chairman of Taylor Sports Group.
[F2]GAT Funding, LLC is an entity controlled by the Reporting Person.
[F3]Fully exercisable and there is no expiration date.
[F4]In connection with the promissory note issuance effective March 6, 2025 and the closing of the initial funding on March 11, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on March 12, 2025.

Documents

1 file